BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9144703)

  • 1. Itraconazole in the treatment of two young brothers with chronic mucocutaneous candidiasis.
    Tosti A; Piraccini BM; Vincenzi C; Cameli N
    Pediatr Dermatol; 1997; 14(2):146-8. PubMed ID: 9144703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic mucocutaneous candidiasis, a case study and literature review.
    Khosravi AR; Mansouri P; Saffarian Z; Vahedi G; Nikaein D
    J Mycol Med; 2018 Mar; 28(1):206-210. PubMed ID: 29500032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for diagnosis and treatment of mucocutaneous candidiasis].
    Katoh T
    Nihon Ishinkin Gakkai Zasshi; 2009; 50(4):207-12. PubMed ID: 19942790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photo quiz. A 32-year-old man with ulcerative mucositis, skin lesions, and nail dystrophy. Chronic mucocutaneous candidiasis by multidrug-resistant Candida albicans.
    Bader O; Weig MS; Gross U; Schön MP; Mempel M; Buhl T
    Clin Infect Dis; 2012 Apr; 54(7):972, 1035-6. PubMed ID: 22403094
    [No Abstract]   [Full Text] [Related]  

  • 5. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
    Hu Y; Hu Y; Lu Y; Huang S; Liu K; Han X; Mao Z; Wu Z; Zhou X
    Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazole therapy for mucocutaneous candidiasis in HIV-infected patients.
    Thomas CJ
    J Assoc Nurses AIDS Care; 1998; 9(5):36-44. PubMed ID: 9742479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic mucocutaneous candidiasis presenting as Candida endophthalmitis.
    Wang Q; Dufresne SF; Vinh DC; Aubin MJ
    Can J Ophthalmol; 2016 Apr; 51(2):e55-8. PubMed ID: 27085277
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis.
    Pedraza-Sánchez S; Méndez-León JI; Gonzalez Y; Ventura-Ayala ML; Herrera MT; Lezana-Fernández JL; Bellanti JA; Torres M
    Front Immunol; 2018; 9():2956. PubMed ID: 30627128
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of itraconazole in a patient with chronic mucocutaneous candidiasis.
    Burke WA
    J Am Acad Dermatol; 1989 Dec; 21(6):1309-10. PubMed ID: 2555403
    [No Abstract]   [Full Text] [Related]  

  • 10. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigliadin antibodies associated with chronic mucocutaneous candidiasis.
    Garcia YH; Díez SG; Aizpún LT; Oliva NP
    Pediatr Dermatol; 2002; 19(5):415-8. PubMed ID: 12383098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():80. PubMed ID: 12043087
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
    Fanconi S; Seger R; Joller P; Issler C; Schär G
    Eur J Pediatr; 1982 Nov; 139(3):176-80. PubMed ID: 6297913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic mucocutaneous candidiasis associated with malignant thymoma and systemic lupus erythematosus with hypergammaglobulinemia: a case report and literature review.
    San Filippo J
    Cutis; 2006 Jul; 78(1):57-60. PubMed ID: 16903322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chronic mucocutaneous candidiasis.
    Rosenblatt HM; Stiehm ER
    Am J Med; 1983 Jan; 74(1B):20-2. PubMed ID: 6295148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
    Carey B; Lambourne J; Porter S; Hodgson T
    Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole.
    Firinu D; Massidda O; Lorrai MM; Serusi L; Peralta M; Barca MP; Serra P; Manconi PE
    Clin Dev Immunol; 2011; 2011():283239. PubMed ID: 21197459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Mucocutaneous Candidiasis.
    Khullar G; Vignesh P; Lau YL; Rudramurthy SM; Rawat A; De D; Handa S; Singh S
    J Allergy Clin Immunol Pract; 2017; 5(4):1119-1121. PubMed ID: 28065688
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketoconazole in a case of chronic mucocutaneous candidiasis.
    Zachariae H; Laurberg G; Thestrup-Pedersen K
    Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.